Source: www.cdsco.nic.in
Introduction:
The Drugs and Cosmetics
Act, 1940 along with the Drugs and Cosmetics Rules, 1945 (“Rules”) made thereunder
regulate the manufacturing, import, circulation and trade of the drugs and
cosmetics industry in India. The objective of these laws is to protect the
consumers from sub-standard, illegal and harmful drugs or cosmetics and
prescribe detailed procedures to be adopted for their manufacturing, packaging
and sale in India.
Import
of manufacture of new drug for clinical trials or marketing:
PART XA of the Rules
deals with import of manufacture of new drug for clinical trials or marketing.
As per the Rules for the import of new drugs, prior approval is required to be
obtained from the Licensing Authority established under the Rules. The said
Rule prescribes inter alia the
procedures for applying for the said approval.
Permission
for import of drugs:
Once the Licensing
Authority is satisfied as to the safety of the drug to be imported as raw
material (bulk drug substance) or as finished formulation it may issue an
import permission in the prescribed forms, subject to the conditions stated
therein.
The Permission as may
be granted will be subject related to the condition related to composition,
packaging, labelling etc. mentioned therein. One such condition is that
“Specimen of the carton, labels, package insert that will be adopted for
marketing the drug in the country shall be approved from the Licensing
Authority before the drug is marketed.”[1]
The
Draft Drugs and Cosmetics (Amendment) Rules, 2018
Recently the Central Government
after consultation with the Drugs Technical Advisory Board proposed amendment to
the Rules. The Draft Drugs and Cosmetics (Amendment) Rules, 2018 proposes to add
another condition in the license granted under Form 45, Form 46 etc. making
inclusion of package inserts in each saleable unit to be provided to the
consumer compulsory. This proposed amendment appears to be in the interests of
consumers as it would ensure that consumers are aware of the details and
instructions accompanying the drug.
No comments:
Post a Comment